Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stratagen Quantitative Prostate MRI Platform Pilot Study
Sponsor: Stratagen Bio, Inc.
Summary
The goal of this clinical trial is to assess the safety and feasibility of the Stratagen Quantitative Prostate MRI Platform when used in addition to the standard scans conducted during the existing prostate MRI sessions. * What severe problems, if any, occur because of the use of the Stratagen Quantitative Prostate MRI Platform? * Can the data collected be used to measure quantitative MRI parameters? Participants will: \- Receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.
Official title: A Pilot Study to Determine Safety and Feasibility of the Stratagen Quantitative Prostate MRI Platform as an Adjunct to Standard of Care MRI When Evaluating for Clinically Significant Prostate Cancer
Key Details
Gender
MALE
Age Range
40 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2025-09-24
Completion Date
2026-10-31
Last Updated
2026-03-06
Healthy Volunteers
No
Conditions
Interventions
MRI
Will receive up to 15 minutes of additional MRI scan time during the existing prostate MRI imaging session.
Locations (2)
Urology Clinic at Sawgrass
Rochester, New York, United States
Virginia Urology
Richmond, Virginia, United States